![Annex 1 draft review © PMS Annex 1 draft review © PMS](/uploads/images/_scale/annex1draftreview16x9_626x351.jpg)
![Abb. 1 - Strategy 1 ©PMS Abb. 1 - Strategy 1 ©PMS](/uploads/images/_scale/strategy116x9_626x352.jpg)
![Abb. 2 - Strategy 2 ©PMS Abb. 2 - Strategy 2 ©PMS](/uploads/images/_scale/strategy216x9_626x352.jpg)
![Autor: Daniele Pandolfi, ©PMS Autor: Daniele Pandolfi, ©PMS](/uploads/images/_scale/danielepandolfi16x9_626x352.jpg)
![Autor: Frank Panofen ©PMS Autor: Frank Panofen ©PMS](/uploads/images/_scale/panofen1416x9_626x352.jpg)
-
- Standards, Guidelines
Impact on Environmental Monitoring Programs
The New EU GMP Annex 1 Draft
Introduction
On December 20th, after intensive research and debates, the draft for a Revision of ANNEX 1 ("Manufacture of Sterile Medicinal Products") of the EU Guideline for GOOD MANUFACTURING PRACTICE for drug products and drug substances was published for public comment. This updated document will…